Alzheimer’s disease treatment developer Acumen Pharma prices upsized IPO at $16

Acumen Pharmaceuticals (ABOS) has set a $16.00 per share price for its upsized IPO of 10 million common shares, with estimated gross proceeds of $160 million. The company originally planned to offer 8.3 million shares at a price of…/nRead More